91 clinical development program management jobs at 50 companies in Peabody, MA
1w
Save
Mark Applied
Hide
1w
Clinical Development Operations Program Lead
Bedford or Waltham
$236k-$260k/yrHybridFull Time
Stoke TherapeuticsNasdaq: STOK: Public biotechnology developing antisense RNA medicines to restore protein expression for severe genetic diseases.
10+ YOEBachelor’s degree required; 10+ years of clinical operations and development program management experience, outsourced CRO leadership, GCP and global regulatory knowledge, risk management, and cross-functional leadership.
TANGO, RNA, Clinical Research Organizations (CROs), Employee Stock Purchase Program (ESPP)
MapLight TherapeuticsNasdaq Global Market: MPLT: Clinical-stage biopharmaceutical developing circuit-specific medicines for patients with central nervous system disorders.
Extensive biotech/pharma clinical development leadership across multi-stage programs; governance participation; strong cross-functional collaboration.
AlkermesNasdaq: ALKS: Public Irish biopharmaceutical developing and commercializing neuroscience medicines for people with psychiatric and neurological disorders.
10+ YOEBachelor's in life sciences (Master's preferred), 10+ years clinical development experience in pharma/biotech or CRO, experience leading global clinical programs including Phase 4/LCM, strong leadership, GCP/ICH knowledge, ability to travel up to 20%.
Beam TherapeuticsNasdaq: BEAM: Public biotechnology developing precision genetic medicines through base editing for patients with serious diseases.
10+ YOEMD/DO or equivalent, 15+ years' experience with 10+ years in clinical development, patient care experience, regulatory interactions, leadership of clinical programs across phases.
Isomorphic Labs: AI-first drug design and development using machine learning to accelerate drug discovery for human health.
Proven track record managing clinical programs from IND through late-stage development, cross-functional leadership, program and budget management, vendor/CRO oversight, strong communication and organizational skills; PMP preferred.
Kiniksa PharmaceuticalsNasdaq: KNSA: Public biopharmaceutical developing and commercializing cardiovascular and immune-modulating therapies for patients with unmet needs.
8+ YOEMD/PhD/PharmD required, 8+ years in clinical research/drug development, experience leading clinical programs, IND/CTA submissions, strong trial design and regulatory knowledge, excellent communication and leadership.
Tango TherapeuticsNasdaq Global Market: TNGX: Clinical-stage biotechnology developing precision cancer medicines and novel drug targets for patients with genetically defined cancers.
5+ YOEMD required; 5+ years clinical development experience in biotech/pharma leading oncology programs. Experience with regulatory submissions (IND/CTA/NDA/MAA), clinical trial design/execution, medical monitoring, and cross‑functional leadership.
Brigham and Women's Hospital: Nonprofit academic medical center providing patient care, biomedical research, and clinical education as a Harvard teaching hospital.
5+ YOE2+ MgmtBA/BS required; master's degree or PhD preferred. Requires at least 2 years of management experience; 5 years of research experience preferred. Oversees clinical research programs, compliance, staff, and studies.
AstraZenecaLondon Stock Exchange: AZN: Global science-led biopharmaceutical.
5+ YOERequires M.D., Ph.D., or equivalent; 5–8 years of clinical development experience; trial design and implementation expertise; biostatistics, regulatory, pharmacovigilance, GCP, and safety knowledge; English communication skills.
Shriners Children's Boston: Specialized pediatric healthcare system providing expert medical care.
3+ YOERequires 3 years of clinical research experience, including site or study management, IRBs, and federal regulations. A clinical research, science, or healthcare degree is preferred; 5 years’ related experience required without a degree.
Kailera TherapeuticsNasdaq Global Select Market: KLRA: Clinical-stage biopharmaceutical developing injectable and oral therapies for obesity.
15+ YOE15+ years clinical development experience with late-stage program leadership, global regulatory interactions, budgeting and resource management; MD or equivalent; ability to travel ~25%; hub-based in Waltham, MA (3-4 days/week).
VP, Clinical Development, Amyloidosis and Rare Cardiology
Boston, Massachusetts, United States
$402k-$603k/yrOnsiteFull Time
Alexion Pharmaceuticals: Private biopharmaceutical developing medicines for patients and families affected by rare diseases.
10+ YOEMD/PhD/PharmD or equivalent with 10+ years industry experience, demonstrated leadership of global IND/BLA/NDA/MAA programs, regulatory and clinical trial expertise, strong communication and strategic planning skills.
Director, Drug Development Project Management & Pipeline Strategy
Cambridge or United Kingdom
$179k-$237k/yrOnsiteFull Time
Quotient Therapeutics: Private biotechnology venture-creation firm that invents and builds platform companies for human health and sustainability.
5+ YOEBachelor’s degree in biological sciences or related field; 5–10 years of drug development experience; complex matrix project management expertise; drug discovery, clinical development, and regulatory strategy knowledge; project management tools proficiency.
Microsoft Project, Smartsheet, Microsoft Office, ChatGPT, Claude, Microsoft Copilot, Notion, Microsoft SharePoint
VP, Clinical Development, Amyloidosis and Rare Cardiology
Boston, Massachusetts, United States
$402k-$603k/yrOnsiteFull Time
Alexion Pharmaceuticals: Alexion is a private biopharmaceutical developing medicines for patients and families affected by rare diseases.
10+ YOEMD preferred (PhD/PharmD considered),10+ years industry drug development experience, leadership of global clinical programs, regulatory filing experience (IND/BLA/NDA/MAA),trial execution and cross-functional collaboration.
TakedaTokyo Stock Exchange: 4502: Global research-driven biopharmaceutical.
10+ YOE5+ Mgmt10+ years pharma experience with 5+ years in Quality; BSc required (MSc/PhD preferred); deep GCP and regulatory knowledge; inspection readiness, investigations, and audit leadership; strong communication and leadership skills.
Rapport TherapeuticsNasdaq Global Market: RAPP: Public clinical-stage biopharmaceutical developing precision small-molecule medicines for neurological and psychiatric disorders.
15+ YOERequires PhD, PharmD, MD, or equivalent relevant advanced degree; 15+ years of biotech or pharmaceutical experience; and leadership of small-molecule programs from discovery through IND and early clinical development.
ModernaNASDAQ: MRNA: Biotechnology focused on mRNA-based medicine and vaccine development.
5+ YOERequires 5+ years of clinical trial coordination experience, a science-based bachelor's degree or advanced degree, global study experience, drug development knowledge, project management skills, and FDA/ICH GCP knowledge.
Editas MedicineNasdaq: EDIT: Public gene-editing biotechnology developing genomic medicines for people with serious diseases.
10+ YOEBachelor’s degree in life sciences or related field; 10+ years in biotech/pharma, including 8+ years in program management for early clinical development; gene therapy, cross-functional leadership, and project planning expertise.
Smartsheet, Microsoft Project, Office Timeline, CRISPR/Cas9, CRISPR/Cpf1, Cas12a
Remix Therapeutics: Clinical-stage biotechnology developing small-molecule therapies that modulate RNA processing for patients with high unmet medical needs.
15+ YOE15+ years of drug development experience with depth across clinical, regulatory and Tech Ops; oncology experience preferred.